Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Specific amyloid beta binding peptides and the use of same for treating and diagnosing alzheimer's dementia

Specific amyloid beta binding peptides and the use of same for treating and diagnosing alzheimer's dementia

US Patent 10239923 · Granted Mar 26, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Amyloid-beta-binding peptides and the use thereof for the treatment and diagnosi2022
Methods of treating chronic and neuropathic pain mediated by N-type neuronal cal2022
Methods of treating chronic and neuropathic pain mediated by N-type neuronal cal2022
Method for detecting indicators for determining diseases2021
Method for detecting indicators for determining diseases2021
Amyloid-beta-binding peptides and the use thereof for the treatment and diagnosi2021
Method for producing a standard for detecting protein aggregates of a protein mi2021
D-enantiomeric peptides derived from D3 and use thereof2021
D-enantiomeric peptides derived from D3 and use thereof2021
Method for treating blood, blood products and organs2020
Method for quantitative characterization of substances with regard to their prop2020
Cyclic, amyloid beta-binding peptides and the use thereof2019